Hutchmed (China) Ltd on Friday said it will receive a milestone payment from Takeda Pharmaceutical Co Ltd after Taked ...
Hutchmed (China) Limited 20 November 2024 HUTCHMED Announces Appointment of Independent Non-executive Director and Member of Board Committee Hong Kong, Shanghai & Florham Park, NJ...
Hutchmed (China) Ltd on Thursday said it will receive a USD20 million payment from its partner Takeda Pharmaceutical ...
Hutchmed (China) Limited 31 October 2024 Total Voting Rights Hong Kong, Shanghai, & Florham Park, NJ – Thursday, October 31, 2024: HUTCHMED (China) Limited ("HUTCHMED") (Nasdaq/AIM:...
Hutchmed (China) Limited 21 October 2024 Vesting of awards under the Long Term Incentive Plan Hong Kong, Shanghai & Florham Park, NJ - Monday, October 21, 2024: HUTCHMED (China) Limited...
Hutchmed China Ltd on Wednesday said that Tagrisso plus Orpathys showed a high clinically meaningful response rate in ...
Hutchmed (China) Limited 16 October 2024 HUTCHMED Announces that TAGRISSO® plus ORPATHYS® demonstrated high, clinically meaningful response rate in lung cancer patients with high levels of...
Takeda Pharmaceutical Co Ltd on Tuesday said it landed an approval for its Fruzaqla drug in Japan. The drug has bee ...
Hutchmed (China) Limited 24 September 2024 HUTCHMED Announces Japan Approval for FRUZAQLA® (fruquintinib) Received by Takeda - Approval based on results from global Phase III FRESCO-2...
Hutchmed (China) Ltd announced on Friday that it has voluntarily withdrawn its supplemental new drug application for ...
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 14 | 5.30303030303 | 264 | 290 | 260 | 59638 | 273.6668064 | DE |
4 | -48 | -14.7239263804 | 326 | 328 | 260 | 67096 | 290.55447402 | DE |
12 | 8 | 2.96296296296 | 270 | 336 | 242 | 139436 | 295.31246104 | DE |
26 | -36 | -11.4649681529 | 314 | 336 | 242 | 99339 | 294.46850649 | DE |
52 | -4.5 | -1.59292035398 | 282.5 | 353 | 190.4 | 88828 | 287.48027243 | DE |
156 | -192 | -40.8510638298 | 470 | 556 | 130 | 104264 | 275.02371332 | DE |
260 | -94 | -25.2688172043 | 372 | 656 | 130 | 101232 | 350.548752 | DE |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관